| abstract |
The present invention relates to a substituted 2- (morpholin-4-yl) -1,7-naphthyridine compound of the general formula (I) or (Ib), n n n The method for preparing these compounds can be used to prepare intermediate compounds of these compounds, pharmaceutical compositions and combinations containing these compounds, and these compounds as the sole agent or in combination with other active ingredients for the manufacture or treatment of diseases Use of a pharmaceutical composition (especially a hyperproliferative disease). |